563 related articles for article (PubMed ID: 12270869)
1. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
Circulation; 2002 Sep; 106(13):1722-8. PubMed ID: 12270869
[TBL] [Abstract][Full Text] [Related]
2. Androgen contributes to gender-related cardiac hypertrophy and fibrosis in mice lacking the gene encoding guanylyl cyclase-A.
Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Hamanaka I; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
Endocrinology; 2004 Feb; 145(2):951-8. PubMed ID: 14592959
[TBL] [Abstract][Full Text] [Related]
3. Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically engineered mice.
Nakanishi M; Saito Y; Kishimoto I; Harada M; Kuwahara K; Takahashi N; Kawakami R; Nakagawa Y; Tanimoto K; Yasuno S; Usami S; Li Y; Adachi Y; Fukamizu A; Garbers DL; Nakao K
Hypertension; 2005 Aug; 46(2):441-7. PubMed ID: 15998711
[TBL] [Abstract][Full Text] [Related]
4. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
[TBL] [Abstract][Full Text] [Related]
5. Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy.
Vellaichamy E; Zhao D; Somanna N; Pandey KN
Physiol Genomics; 2007 Oct; 31(2):193-202. PubMed ID: 17566078
[TBL] [Abstract][Full Text] [Related]
6. Local actions of atrial natriuretic peptide counteract angiotensin II stimulated cardiac remodeling.
Kilić A; Bubikat A; Gassner B; Baba HA; Kuhn M
Endocrinology; 2007 Sep; 148(9):4162-9. PubMed ID: 17510245
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage.
Niu P; Shindo T; Iwata H; Iimuro S; Takeda N; Zhang Y; Ebihara A; Suematsu Y; Kangawa K; Hirata Y; Nagai R
Circulation; 2004 Apr; 109(14):1789-94. PubMed ID: 14967720
[TBL] [Abstract][Full Text] [Related]
8. Guanylyl cyclase-A inhibits angiotensin II type 2 receptor-mediated pro-hypertrophic signaling in the heart.
Li Y; Saito Y; Kuwahara K; Rong X; Kishimoto I; Harada M; Adachi Y; Nakanishi M; Kinoshita H; Horiuchi M; Murray M; Nakao K
Endocrinology; 2009 Aug; 150(8):3759-65. PubMed ID: 19372206
[TBL] [Abstract][Full Text] [Related]
9. Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice.
Harada K; Komuro I; Shiojima I; Hayashi D; Kudoh S; Mizuno T; Kijima K; Matsubara H; Sugaya T; Murakami K; Yazaki Y
Circulation; 1998 May; 97(19):1952-9. PubMed ID: 9609089
[TBL] [Abstract][Full Text] [Related]
10. The specific mineralocorticoid receptor blocker eplerenone attenuates left ventricular remodeling in mice lacking the gene encoding guanylyl cyclase-A.
Zhang Q; Saito Y; Naya N; Imagawa K; Somekawa S; Kawata H; Takeda Y; Uemura S; Kishimoto I; Nakao K
Hypertens Res; 2008 Jun; 31(6):1251-6. PubMed ID: 18716375
[TBL] [Abstract][Full Text] [Related]
11. AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats.
Nagata K; Somura F; Obata K; Odashima M; Izawa H; Ichihara S; Nagasaka T; Iwase M; Yamada Y; Nakashima N; Yokota M
Hypertension; 2002 Aug; 40(2):168-74. PubMed ID: 12154108
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension.
Ichihara S; Senbonmatsu T; Price E; Ichiki T; Gaffney FA; Inagami T
Circulation; 2001 Jul; 104(3):346-51. PubMed ID: 11457756
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling.
Paradis P; Dali-Youcef N; Paradis FW; Thibault G; Nemer M
Proc Natl Acad Sci U S A; 2000 Jan; 97(2):931-6. PubMed ID: 10639182
[TBL] [Abstract][Full Text] [Related]
14. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy.
Kishimoto I; Rossi K; Garbers DL
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2703-6. PubMed ID: 11226303
[TBL] [Abstract][Full Text] [Related]
15. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.
Holtwick R; van Eickels M; Skryabin BV; Baba HA; Bubikat A; Begrow F; Schneider MD; Garbers DL; Kuhn M
J Clin Invest; 2003 May; 111(9):1399-407. PubMed ID: 12727932
[TBL] [Abstract][Full Text] [Related]
16. Heparin cofactor II protects against angiotensin II-induced cardiac remodeling via attenuation of oxidative stress in mice.
Sumitomo-Ueda Y; Aihara K; Ise T; Yoshida S; Ikeda Y; Uemoto R; Yagi S; Iwase T; Ishikawa K; Hirata Y; Akaike M; Sata M; Kato S; Matsumoto T
Hypertension; 2010 Sep; 56(3):430-6. PubMed ID: 20660821
[TBL] [Abstract][Full Text] [Related]
17. Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis.
Kurisu S; Ozono R; Oshima T; Kambe M; Ishida T; Sugino H; Matsuura H; Chayama K; Teranishi Y; Iba O; Amano K; Matsubara H
Hypertension; 2003 Jan; 41(1):99-107. PubMed ID: 12511537
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors.
Ishiyama Y; Gallagher PE; Averill DB; Tallant EA; Brosnihan KB; Ferrario CM
Hypertension; 2004 May; 43(5):970-6. PubMed ID: 15007027
[TBL] [Abstract][Full Text] [Related]
19. Ventricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibrosis.
Ellmers LJ; Knowles JW; Kim HS; Smithies O; Maeda N; Cameron VA
Am J Physiol Heart Circ Physiol; 2002 Aug; 283(2):H707-14. PubMed ID: 12124219
[TBL] [Abstract][Full Text] [Related]
20. Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice.
Liu Y; Gao L; Guo S; Liu Y; Zhao X; Li R; Yan X; Li Y; Wang S; Niu X; Yao L; Zhang Y; Li L; Yang H
Cell Physiol Biochem; 2017; 43(6):2253-2263. PubMed ID: 29073623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]